Cardinal Steps Up Generics Focus By Establishing “Cross-Segment” Team
This article was originally published in The Pink Sheet Daily
Executive Summary
Wholesaler downplays effect of Wal-Mart generics program.
You may also be interested in...
Wal-Mart Generic Rx Program Expansion Underway With Addition Of 12 More States
Retailer plans to continue expanding its $4 generic drug program to as many states as possible.
Cardinal Plans Expanded Role In Generic Rx Sector
The wholesaler will "participate more in the value chain" for generics via partnerships and use of in-house manufacturing capacity. "Don't interpret that to mean we are going to go buy a generic manufacturer now," CEO Walter says.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.